MedPath

Carponovum AB

🇸🇪Sweden
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:1

Trial Phases

1 Phases

Not Applicable:3

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Not Applicable
3 (100.0%)

Clinical Validation of C-REX Device for Adaptive Anastomoses

Not Applicable
Conditions
Cancer Colonic
First Posted Date
2021-04-08
Last Posted Date
2021-04-12
Lead Sponsor
Carponovum AB
Target Recruit Count
200
Registration Number
NCT04836676
Locations
🇸🇪

Danderyds Sjukhus, Danderyd, Stockholm, Sweden

🇸🇪

Capio Saint Göran's Sjukhus, Stockholm, Sweden

🇸🇪

Ersta diakoni, Stockholm, Sweden

and more 2 locations

Clinical Study Verifying C-REX LapAid in Clinical Practice

Not Applicable
Terminated
Conditions
Cancer Colonic
First Posted Date
2018-01-19
Last Posted Date
2020-04-30
Lead Sponsor
Carponovum AB
Target Recruit Count
13
Registration Number
NCT03404934
Locations
🇨🇳

Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China

Clinical Trial Verifying C-REX LapAid and C-REX DMH/DMHC

Not Applicable
Completed
Conditions
Polyp of Colon
Cancer Colon
First Posted Date
2017-06-07
Last Posted Date
2018-01-17
Lead Sponsor
Carponovum AB
Target Recruit Count
20
Registration Number
NCT03179358
Locations
🇨🇳

The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.